Dominari (NASDAQ:DOMH) Trading Up 2.3% – Here’s What Happened

Dominari Holdings Inc. (NASDAQ:DOMH)’s share price was up 2.3% on Monday . The stock traded as high as $3.22 and last traded at $3.17. Approximately 110,744 shares traded hands during mid-day trading, a decline of 58% from the average daily volume of 266,336 shares. The stock had previously closed at $3.10.

Analyst Ratings Changes

Separately, Wall Street Zen raised Dominari from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has an average rating of “Sell”.

Dominari Stock Down 4.0%

The stock has a market capitalization of $70.54 million, a price-to-earnings ratio of -0.77 and a beta of 0.80. The firm has a 50-day moving average of $3.15 and a two-hundred day moving average of $3.62.

Dominari (NASDAQ:DOMH) last issued its earnings results on Wednesday, May 13th. The company reported ($2.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.17) by ($1.94). Dominari had a negative net margin of 31.37% and a negative return on equity of 206.20%. The firm had revenue of $35.81 million during the quarter, compared to analysts’ expectations of $35.81 million.

Dominari Announces Dividend

The business also recently declared a special dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were paid a dividend of $0.31 per share. The ex-dividend date was Friday, May 15th.

Institutional Trading of Dominari

Several hedge funds have recently added to or reduced their stakes in the business. Creek Drive Management Group LLC bought a new stake in shares of Dominari in the 4th quarter worth approximately $1,861,000. Vanguard Group Inc. lifted its position in shares of Dominari by 8.0% during the 3rd quarter. Vanguard Group Inc. now owns 345,896 shares of the company’s stock worth $2,452,000 after buying an additional 25,694 shares during the period. Connective Capital Management LLC lifted its position in shares of Dominari by 26.2% during the 3rd quarter. Connective Capital Management LLC now owns 335,273 shares of the company’s stock worth $2,377,000 after buying an additional 69,545 shares during the period. Renaissance Technologies LLC lifted its position in shares of Dominari by 59.1% during the 1st quarter. Renaissance Technologies LLC now owns 132,362 shares of the company’s stock worth $430,000 after buying an additional 49,162 shares during the period. Finally, Two Sigma Investments LP bought a new position in shares of Dominari during the 3rd quarter worth approximately $771,000. Institutional investors own 42.48% of the company’s stock.

Dominari Company Profile

Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2.